Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors

Por Gazdar, AF
Publicado em 2009

DNA Methylation Based Biomarkers in Non-Invasive Cancer Screening

Por Shivapurkar, N., Gazdar, A.F.
Publicado em 2010

DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers

Por Lockwood, WW, Chari, R, Coe, BP, Girard, L, MacAulay, C, Lam, S, Gazdar, AF, Minna, JD, Lam, WL
Publicado em 2008

Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer

Por Sunaga, N, Kaira, K, Imai, H, Shimizu, K, Nakano, T, Shames, DS, Girard, L, Soh, J, Sato, M, Iwasaki, Y, Ishizuka, T, Gazdar, AF, Minna, JD, Mori, M
Publicado no Oncogene (2012)

Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer

Por Kwei, KA, Kim, YH, Girard, L, Kao, J, Pacyna-Gengelbach, M, Salari, K, Lee, J, Choi, Y-L, Sato, M, Wang, P, Hernandez-Boussard, T, Gazdar, AF, Petersen, I, Minna, JD, Pollack, JR
Publicado em 2008

Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1α in non-small cell lung cancer cells

Por Xu, L, Nilsson, MB, Saintigny, P, Cascone, T, Herynk, MH, Du, Z, Nikolinakos, PG, Yang, Y, Prudkin, L, Liu, D, Lee, JJ, Johnson, FM, Wong, K-K, Girard, L, Gazdar, AF, Minna, JD, Kurie, JM, Wistuba, II, Heymach, JV
Publicado em 2010